Letter on 'European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis'.
J Eur Acad Dermatol Venereol 2017 Dec 28. Epub 2017 Dec 28.
Consultant Cardiovascular Radiologist NHS Greater Glasgow & Clyde Honorary Clinical Associate Professor, Glasgow University President British Society of Cardiovascular Imaging / British Society of Cardiovascular CT, Glasgow, Scotland, United Kingdom.
We read with interest the guidelines recently published on sclerosing diseases of the skin (Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis)[1, 2]. However, we are concerned that the guideline recommendations proposed for prevention of nephrogenic systemic fibrosis (NSF) are potentially dangerous. Although we recognise the challenges in constructing comprehensive guidelines, we are concerned that this may be because the guidelines have not involved a multidisciplinary team. Read More